Delta-Fly Pharma, Inc. (4598.T)
JPY 460.0
(-7.26%)
JPY 460.0
(-7.26%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.42 Billion JPY | -7.57% |
| 2022 | -1.32 Billion JPY | -37.37% |
| 2021 | -967.3 Million JPY | -12.14% |
| 2020 | -862.58 Million JPY | 44.53% |
| 2019 | -1.55 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -500 Thousand JPY | 3.38% |
| 2023 FY | -1.42 Billion JPY | -7.57% |
| 2023 Q1 | -280.66 Million JPY | 3.38% |
| 2023 Q4 | -456.49 Million JPY | -22.51% |
| 2023 Q3 | -372.61 Million JPY | -16.58% |
| 2023 Q2 | -319.62 Million JPY | -13.88% |
| 2022 Q3 | -416 Million JPY | -32.52% |
| 2022 Q4 | -290.48 Million JPY | 30.17% |
| 2022 FY | -1.32 Billion JPY | -37.37% |
| 2022 Q2 | -313.91 Million JPY | 0.0% |
| 2021 FY | -967.3 Million JPY | -12.14% |
| 2020 FY | -862.58 Million JPY | 44.53% |
| 2019 FY | -1.55 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 384 Million JPY | 472.238% |
| PRISM BioLab Co.,LTD | -526.91 Million JPY | -171.276% |
| GNI Group Ltd. | 8.09 Billion JPY | 117.659% |
| Linical Co., Ltd. | 338.26 Million JPY | 522.565% |
| Trans Genic Inc. | 4.08 Million JPY | 35091.261% |
| MEDINET Co., Ltd. | -1.43 Billion JPY | 0.595% |
| Soiken Holdings Inc. | -662.2 Million JPY | -115.854% |
| Cytori Cell Research Institute, Inc. | 138.15 Million JPY | 1134.63% |
| AnGes, Inc. | -7.43 Billion JPY | 80.782% |
| OncoTherapy Science, Inc. | -1.28 Billion JPY | -10.966% |
| Nxera Pharma Co., Ltd. | -7.19 Billion JPY | 80.128% |
| Immuno-Biological Laboratories Co., Ltd. | 186.69 Million JPY | 865.634% |
| NanoCarrier Co., Ltd. | -780 Million JPY | -83.255% |
| Carna Biosciences, Inc. | -1.15 Billion JPY | -23.983% |
| CanBas Co., Ltd. | -1.2 Billion JPY | -18.229% |
| D. Western Therapeutics Institute, Inc. | -812.41 Million JPY | -75.945% |
| RaQualia Pharma Inc. | -323.66 Million JPY | -341.631% |
| Chiome Bioscience Inc. | -1.22 Billion JPY | -17.162% |
| Kidswell Bio Corporation | -1.42 Billion JPY | -0.514% |
| PeptiDream Inc. | 3.03 Billion JPY | 147.084% |
| Oncolys BioPharma Inc. | -1.93 Billion JPY | 26.263% |
| Ribomic Inc. | -1.02 Billion JPY | -39.557% |
| SanBio Company Limited | -2.64 Billion JPY | 45.938% |
| Healios K.K. | -3.82 Billion JPY | 62.611% |
| BrightPath Biotherapeutics Co., Ltd. | -1.16 Billion JPY | -22.371% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.48 Billion JPY | 4.042% |
| StemRIM | -2.02 Billion JPY | 29.308% |
| CellSource Co., Ltd. | 923.14 Million JPY | 254.84% |
| FunPep Company Limited | -933.41 Million JPY | -53.136% |
| Kringle Pharma, Inc. | -854.15 Million JPY | -67.347% |
| Stella Pharma Corporation | -763.74 Million JPY | -87.155% |
| TMS Co., Ltd. | -960.04 Million JPY | -48.889% |
| Noile-Immune Biotech Inc. | -1.13 Billion JPY | -26.493% |
| Cuorips Inc. | -632.18 Million JPY | -126.104% |
| K Pharma,Inc. | 260.33 Million JPY | 649.07% |
| Takara Bio Inc. | 1.48 Billion JPY | 196.581% |
| ReproCELL Incorporated | -31.41 Million JPY | -4450.033% |
| PhoenixBio Co., Ltd. | 26.37 Million JPY | 5518.883% |
| StemCell Institute Inc. | 310.98 Million JPY | 559.64% |
| Japan Tissue Engineering Co., Ltd. | 143.16 Million JPY | 1098.396% |
| CellSeed Inc. | -846.53 Million JPY | -68.852% |